Whole-lesion histogram and texture analyses of breast lesions on inline quantitative DCE mapping with CAIPIRINHA-Dixon-TWIST-VIBE

Purpose To investigate the diagnostic capability of whole-lesion (WL) histogram and texture analysis of dynamic contrast-enhanced (DCE) MRI inline-generated quantitative parametric maps using CAIPIRINHA-Dixon-TWIST-VIBE (CDTV) to differentiate malignant from benign breast lesions and breast cancer subtypes. Materials and methods From February 2018 to November 2018, DCE MRI using CDTV was performed on 211 patients. The inline-generated parametric maps included K trans , k ep , V e , and IAUGC 60 . Histogram and texture features were extracted from the above parametric maps respectively based on a WL analysis. Student’s t tests, one-way ANOVAs, Mann-Whitney U tests, Jonckheere-Terpstra tests, and ROC curves were used for statistical analysis. Results Compared with benign breast lesions, malignant breast lesions showed significantly higher K trans _median, 5th percentile, entropy, and diff-entropy , IAUGC 60_median, 5th percentile, entropy, and diff-entropy , k ep_mean, median, 5th percentile, entropy, and diff-entropy , and V e_95th percentile, diff-variance, and contrast , and significantly lower k ep_skewness and V e_SD, entropy, diff-entropy, and skewness (all p  ≤ 0.011). The combination of all the extracted parameters yielded an AUC of 0.85 (sensitivity 76%, specificity 86%). k ep_contrast showed a significant difference among different subtypes of breast cancer ( p  = 0.006). k ep_skewness showed a significant difference between lymph node–positive and lymph node–negative breast cancer ( p  = 0.007). The IAGC 60_5th percentile had an AUC of 0.71 (sensitivity 50%, specificity 91%) for differentiating between high- and low-proliferation groups of breast cancer. Conclusions The WL histogram and texture analyses of CDTV-DCE-derived parameters may give additional information for further evaluation of breast cancer. Key Points • Inline DCE mapping with CDTV is effective and time-saving. • WL histogram and texture-extracted features could distinguish breast cancer from benign lesions accurately. • k ep_contrast , k ep_skewness , and IAUGC 60_5th percentile could predict breast cancer subtypes, lymph node metastasis, and proliferation abilities, respectively.

[1]  Dukyong Yoon,et al.  Is there any correlation between model-based perfusion parameters and model-free parameters of time-signal intensity curve on dynamic contrast enhanced MRI in breast cancer patients? , 2014, European Radiology.

[2]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[3]  Gustav Andreisek,et al.  Delayed gadolinium-enhanced MR imaging of articular cartilage: three-dimensional T1 mapping with variable flip angles and B1 correction. , 2009, Radiology.

[4]  Hans-Peter Sinn,et al.  A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition , 2013, Breast Care.

[5]  I. Kamel,et al.  Improved Detection of Recurrent Hepatocellular Carcinomas in Arterial Phase With CAIPIRINHA-Dixon-TWIST-Volumetric Interpolated Breath-Hold Examination , 2016, Investigative radiology.

[6]  CAIPIRINHA-Dixon-TWIST (CDT)-VIBE MR imaging of the liver at 3.0T with gadoxetate disodium: a solution for transient arterial-phase respiratory motion-related artifacts? , 2018, European Radiology.

[7]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[8]  Yajia Gu,et al.  Feasibility study of dual parametric 2D histogram analysis of breast lesions with dynamic contrast-enhanced and diffusion-weighted MRI , 2018, Journal of Translational Medicine.

[9]  Walter H Backes,et al.  The precision of pharmacokinetic parameters in dynamic contrast-enhanced magnetic resonance imaging: the effect of sampling frequency and duration , 2011, Physics in medicine and biology.

[10]  R. Lerski,et al.  Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer , 2017, European Radiology.

[11]  N. Harbeck Insights into biology of luminal HER2 vs. enriched HER2 subtypes: Therapeutic implications. , 2015, Breast.

[12]  Jin You Kim,et al.  Dynamic contrast‐enhanced and diffusion‐weighted MRI of estrogen receptor‐positive invasive breast cancers: Associations between quantitative MR parameters and Ki‐67 proliferation status , 2017, Journal of magnetic resonance imaging : JMRI.

[13]  Lihua Li,et al.  Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging , 2018, European Radiology.

[14]  Thierry Metens,et al.  Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy , 2016, European Radiology.

[15]  Kyunghyun Sung,et al.  Transmit B1+ field inhomogeneity and T1 estimation errors in breast DCE‐MRI at 3 tesla , 2013, Journal of magnetic resonance imaging : JMRI.

[16]  Glen R Morrell,et al.  Pharmacokinetic mapping for lesion classification in dynamic breast MRI , 2010, Journal of magnetic resonance imaging : JMRI.

[17]  C. Schraml,et al.  Feasibility of CAIPIRINHA-Dixon-TWIST-VIBE for dynamic contrast-enhanced MRI of the prostate. , 2015, European journal of radiology.

[18]  Karel G M Moons,et al.  Meta-analysis of MR imaging in the diagnosis of breast lesions. , 2008, Radiology.

[19]  Lindsay W. Turnbull,et al.  Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators , 2014, European Radiology.

[20]  G. Wright,et al.  Rapid high‐resolution T1 mapping by variable flip angles: Accurate and precise measurements in the presence of radiofrequency field inhomogeneity , 2006, Magnetic resonance in medicine.

[21]  Tao Ai,et al.  Application of whole‐lesion histogram analysis of pharmacokinetic parameters in dynamic contrast‐enhanced MRI of breast lesions with the CAIPIRINHA‐Dixon‐TWIST‐VIBE technique , 2018, Journal of magnetic resonance imaging : JMRI.

[22]  Thomas E Yankeelov,et al.  A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer , 2011, Physics in medicine and biology.

[23]  M. Cheang,et al.  Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib. , 2016, JAMA oncology.

[24]  V. Jellús,et al.  Variable flip angle‐based fast three‐dimensional T1 mapping for delayed gadolinium‐enhanced MRI of cartilage of the knee: Need for B1 correction , 2011, Magnetic resonance in medicine.

[25]  Guangbin Wang,et al.  Influence of scan duration on the estimation of pharmacokinetic parameters for breast lesions: a study based on CAIPIRINHA-Dixon-TWIST-VIBE technique , 2015, European Radiology.

[26]  R. A. Lerski,et al.  Magnetic resonance imaging texture analysis classification of primary breast cancer , 2016, European Radiology.

[27]  Wei Huang,et al.  Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging. , 2011, Radiology.

[28]  Piotr Kozlowski,et al.  Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer. , 2010, Academic radiology.

[29]  Eun Sook Ko,et al.  Breast cancer heterogeneity: MR Imaging Texture Analysis and Survival Outcomes1 , 2016 .

[30]  E. Rostrup,et al.  Measurement of the arterial concentration of Gd‐DTPA using MRI: A step toward quantitative perfusion imaging , 1996, Magnetic resonance in medicine.

[31]  Woo Kyung Moon,et al.  Early Prediction of Response to Neoadjuvant Chemotherapy Using Parametric Response , 2015 .